Tecogen (TGEN)
(Delayed Data from OTC)
$0.80 USD
+0.07 (9.25%)
Updated Apr 26, 2024 01:56 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Tecogen Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 25 | 25 | 24 | 28 | 33 |
Cost Of Goods | 15 | 14 | 13 | 17 | 21 |
Gross Profit | 10 | 11 | 12 | 11 | 12 |
Selling & Adminstrative & Depr. & Amort Expenses | 15 | 13 | 13 | 17 | 17 |
Income After Depreciation & Amortization | -4 | -2 | -1 | -6 | -5 |
Non-Operating Income | 0 | 0 | 5 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -4 | -2 | 4 | -6 | -5 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -5 | -2 | 4 | -6 | -5 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -5 | -2 | 4 | -6 | -5 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -4 | -2 | -1 | -3 | -1 |
Depreciation & Amortization (Cash Flow) | 1 | 0 | 0 | 3 | 4 |
Income After Depreciation & Amortization | -4 | -2 | -1 | -6 | -5 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 24.85 | 24.85 | 25.12 | 24.85 | 24.84 |
Diluted EPS Before Non-Recurring Items | -0.19 | -0.10 | 0.15 | -0.16 | -0.07 |
Diluted Net EPS (GAAP) | -0.19 | -0.10 | 0.15 | -0.25 | -0.19 |
Fiscal Year end for Tecogen Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 5.90 | 7.11 | 6.75 | 5.38 |
Cost Of Goods | NA | 3.55 | 4.19 | 3.91 | 3.29 |
Gross Profit | NA | 2.35 | 2.93 | 2.83 | 2.09 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 4.16 | 3.29 | 3.62 | 3.54 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -1.81 | -0.36 | -0.79 | -1.45 |
Non-Operating Income | NA | -0.02 | -0.07 | 0.02 | 0.00 |
Interest Expense | NA | 0.01 | 0.01 | 0.00 | 0.00 |
Pretax Income | NA | -1.83 | -0.45 | -0.77 | -1.45 |
Income Taxes | NA | 0.00 | 0.00 | 0.01 | 0.02 |
Minority Interest | NA | 0.02 | 0.03 | 0.00 | 0.02 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -1.83 | -0.45 | -0.78 | -1.47 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.85 | -0.48 | -0.78 | -1.49 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 24.85 | 24.85 | 24.85 | 24.85 |
Diluted EPS Before Non-Recurring Items | NA | -0.07 | -0.02 | -0.03 | -0.06 |
Diluted Net EPS (GAAP) | NA | -0.08 | -0.02 | -0.03 | -0.06 |